Safety and Efficacy Study of ONGLYZA (Saxagliptin) Under Conditions of Actual Use

NCT01223456 · clinicaltrials.gov ↗
TERMINATED
Status
542
Enrollment
INDUSTRY
Sponsor class

Stopped Inability to recruit adequate number of patients within the specified time period.

Conditions

Sponsor

AstraZeneca